nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—DRD3—attention deficit hyperactivity disorder	0.376	0.449	CbGaD
Buspirone—DRD2—attention deficit hyperactivity disorder	0.26	0.311	CbGaD
Buspirone—HTR2A—attention deficit hyperactivity disorder	0.201	0.24	CbGaD
Buspirone—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00507	0.168	CbGeAlD
Buspirone—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00269	0.0892	CbGeAlD
Buspirone—DRD3—nervous system—attention deficit hyperactivity disorder	0.00122	0.0404	CbGeAlD
Buspirone—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00117	0.0389	CbGeAlD
Buspirone—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00117	0.0389	CbGeAlD
Buspirone—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00105	0.0349	CbGeAlD
Buspirone—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000993	0.0329	CbGeAlD
Buspirone—DRD2—forebrain—attention deficit hyperactivity disorder	0.000951	0.0315	CbGeAlD
Buspirone—DRD3—brain—attention deficit hyperactivity disorder	0.000933	0.0309	CbGeAlD
Buspirone—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00089	0.0295	CbGeAlD
Buspirone—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000695	0.023	CbGeAlD
Buspirone—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000638	0.0211	CbGeAlD
Buspirone—DRD2—midbrain—attention deficit hyperactivity disorder	0.000628	0.0208	CbGeAlD
Buspirone—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000627	0.0208	CbGeAlD
Buspirone—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000614	0.0203	CbGeAlD
Buspirone—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000571	0.0189	CbGeAlD
Buspirone—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000571	0.0189	CbGeAlD
Buspirone—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.00055	0.0182	CbGeAlD
Buspirone—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000538	0.0178	CbGeAlD
Buspirone—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00053	0.0176	CbGeAlD
Buspirone—DRD2—nervous system—attention deficit hyperactivity disorder	0.000516	0.0171	CbGeAlD
Buspirone—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000497	0.0165	CbGeAlD
Buspirone—HTR2B—brain—attention deficit hyperactivity disorder	0.000487	0.0161	CbGeAlD
Buspirone—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000486	0.0161	CbGeAlD
Buspirone—HTR1A—brain—attention deficit hyperactivity disorder	0.000437	0.0145	CbGeAlD
Buspirone—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000414	0.0137	CbGeAlD
Buspirone—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000411	0.0136	CbGeAlD
Buspirone—DRD2—brain—attention deficit hyperactivity disorder	0.000395	0.0131	CbGeAlD
Buspirone—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000348	0.0115	CbGeAlD
Buspirone—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000341	0.0113	CbGeAlD
Buspirone—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000328	0.0109	CbGeAlD
Buspirone—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.00032	0.0106	CbGeAlD
Buspirone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000315	0.0104	CbGeAlD
Buspirone—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00031	0.0103	CbGeAlD
Buspirone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000304	0.0101	CbGeAlD
Buspirone—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000299	0.00989	CbGeAlD
Buspirone—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000292	0.00967	CbGeAlD
Buspirone—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000271	0.00899	CbGeAlD
Buspirone—HTR2A—brain—attention deficit hyperactivity disorder	0.00026	0.00862	CbGeAlD
Buspirone—CYP2D6—brain—attention deficit hyperactivity disorder	0.000237	0.00785	CbGeAlD
Buspirone—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000223	0.00739	CbGeAlD
Buspirone—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000215	0.00712	CbGeAlD
Buspirone—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00021	0.00696	CbGeAlD
Buspirone—ABCB1—brain—attention deficit hyperactivity disorder	0.000171	0.00565	CbGeAlD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.08e-05	0.000609	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.05e-05	0.000607	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.92e-05	0.000597	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	7.79e-05	0.000587	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.76e-05	0.000585	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.65e-05	0.000577	CbGpPWpGaD
Buspirone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	7.62e-05	0.000574	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.61e-05	0.000574	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.6e-05	0.000573	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.57e-05	0.000571	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.52e-05	0.000567	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.52e-05	0.000567	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.33e-05	0.000553	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.21e-05	0.000543	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.15e-05	0.000539	CbGpPWpGaD
Buspirone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.12e-05	0.000537	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.12e-05	0.000537	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.12e-05	0.000537	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.04e-05	0.000531	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.04e-05	0.000531	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7e-05	0.000528	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.9e-05	0.00052	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.81e-05	0.000513	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.7e-05	0.000505	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.67e-05	0.000503	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.65e-05	0.000501	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.63e-05	0.0005	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.56e-05	0.000495	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.54e-05	0.000493	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.49e-05	0.00049	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.44e-05	0.000485	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.34e-05	0.000478	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.33e-05	0.000477	CbGpPWpGaD
Buspirone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.25e-05	0.000471	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.25e-05	0.000471	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.23e-05	0.00047	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.23e-05	0.00047	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.2e-05	0.000468	CbGpPWpGaD
Buspirone—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.19e-05	0.000466	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.18e-05	0.000466	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.15e-05	0.000464	CbGpPWpGaD
Buspirone—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.15e-05	0.000463	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	6.1e-05	0.00046	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.1e-05	0.00046	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.08e-05	0.000459	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.06e-05	0.000457	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.04e-05	0.000456	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.97e-05	0.00045	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.96e-05	0.000449	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.9e-05	0.000445	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	5.83e-05	0.000439	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.73e-05	0.000432	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.73e-05	0.000432	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.68e-05	0.000428	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.64e-05	0.000425	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.56e-05	0.000419	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.49e-05	0.000414	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.45e-05	0.000411	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.36e-05	0.000404	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.36e-05	0.000404	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.33e-05	0.000402	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.29e-05	0.000398	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.28e-05	0.000398	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.28e-05	0.000398	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.27e-05	0.000397	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.16e-05	0.000389	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.13e-05	0.000387	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.11e-05	0.000385	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.03e-05	0.000379	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.02e-05	0.000379	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.96e-05	0.000374	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.96e-05	0.000374	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.93e-05	0.000372	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.91e-05	0.00037	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.87e-05	0.000367	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.84e-05	0.000365	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.8e-05	0.000362	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.79e-05	0.000361	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.78e-05	0.000361	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.77e-05	0.00036	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.68e-05	0.000353	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.67e-05	0.000352	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.65e-05	0.00035	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.64e-05	0.00035	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.62e-05	0.000349	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.62e-05	0.000348	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.62e-05	0.000348	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.6e-05	0.000347	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.59e-05	0.000346	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.56e-05	0.000344	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.55e-05	0.000343	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.51e-05	0.00034	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.46e-05	0.000336	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.3e-05	0.000324	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.28e-05	0.000323	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.25e-05	0.000321	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.25e-05	0.00032	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.2e-05	0.000317	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.2e-05	0.000316	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.19e-05	0.000316	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.18e-05	0.000315	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.18e-05	0.000315	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.16e-05	0.000314	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.14e-05	0.000312	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.13e-05	0.000311	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.08e-05	0.000307	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.08e-05	0.000307	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.07e-05	0.000307	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.07e-05	0.000307	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.05e-05	0.000305	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.04e-05	0.000305	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.04e-05	0.000305	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.02e-05	0.000303	CbGpPWpGaD
Buspirone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.02e-05	0.000303	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4e-05	0.000301	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.98e-05	0.0003	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.91e-05	0.000294	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.89e-05	0.000293	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.76e-05	0.000284	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.76e-05	0.000283	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.75e-05	0.000283	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.7e-05	0.000279	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.7e-05	0.000279	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.67e-05	0.000277	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.65e-05	0.000275	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.65e-05	0.000275	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.64e-05	0.000274	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.61e-05	0.000272	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.59e-05	0.000271	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.58e-05	0.00027	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.58e-05	0.00027	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.58e-05	0.00027	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.58e-05	0.00027	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.53e-05	0.000266	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.52e-05	0.000265	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.52e-05	0.000265	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.51e-05	0.000265	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.48e-05	0.000263	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.48e-05	0.000262	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.45e-05	0.00026	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	3.42e-05	0.000258	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.42e-05	0.000258	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.41e-05	0.000257	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.4e-05	0.000257	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	3.37e-05	0.000254	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.36e-05	0.000253	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.3e-05	0.000249	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.25e-05	0.000245	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.25e-05	0.000245	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.24e-05	0.000244	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.24e-05	0.000244	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.24e-05	0.000244	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.21e-05	0.000242	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.2e-05	0.000241	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.16e-05	0.000238	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.13e-05	0.000236	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.05e-05	0.00023	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.01e-05	0.000227	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.94e-05	0.000222	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.94e-05	0.000222	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.84e-05	0.000214	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.83e-05	0.000214	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.83e-05	0.000213	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.83e-05	0.000213	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.74e-05	0.000207	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.74e-05	0.000206	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.74e-05	0.000206	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.7e-05	0.000204	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.7e-05	0.000203	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.66e-05	0.000201	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.63e-05	0.000199	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.63e-05	0.000198	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.61e-05	0.000197	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.6e-05	0.000196	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.55e-05	0.000192	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.51e-05	0.000189	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.48e-05	0.000187	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.48e-05	0.000187	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.48e-05	0.000187	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	2.47e-05	0.000186	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.47e-05	0.000186	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.47e-05	0.000186	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.44e-05	0.000184	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	2.43e-05	0.000183	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.38e-05	0.00018	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.31e-05	0.000174	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.31e-05	0.000174	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.3e-05	0.000173	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.26e-05	0.000171	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.22e-05	0.000168	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.000165	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.17e-05	0.000163	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.16e-05	0.000163	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.13e-05	0.000161	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.09e-05	0.000158	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	2.07e-05	0.000156	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	2.06e-05	0.000155	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.02e-05	0.000152	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.01e-05	0.000152	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.98e-05	0.00015	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.98e-05	0.000149	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.95e-05	0.000147	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.92e-05	0.000145	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.92e-05	0.000145	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.9e-05	0.000143	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.89e-05	0.000142	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.88e-05	0.000142	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.87e-05	0.000141	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.87e-05	0.000141	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.86e-05	0.000141	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.84e-05	0.000138	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.76e-05	0.000133	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.76e-05	0.000133	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.74e-05	0.000131	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.74e-05	0.000131	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.73e-05	0.00013	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.71e-05	0.000129	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.67e-05	0.000126	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.62e-05	0.000122	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.61e-05	0.000121	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.5e-05	0.000113	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.49e-05	0.000112	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.49e-05	0.000112	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	0.000107	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.41e-05	0.000106	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.41e-05	0.000106	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	0.000101	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.24e-05	9.32e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.15e-05	8.67e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.15e-05	8.67e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.13e-05	8.53e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.13e-05	8.53e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.12e-05	8.47e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.07e-05	8.03e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.06e-05	7.98e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.05e-05	7.93e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.2e-06	6.94e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.19e-06	6.93e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	8.89e-06	6.7e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.75e-06	6.6e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.56e-06	6.45e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.46e-06	5.62e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.97e-06	5.25e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.92e-06	5.22e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.55e-06	4.94e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.45e-06	4.86e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.43e-06	4.84e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.85e-06	3.66e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.57e-06	3.45e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.99e-06	2.25e-05	CbGpPWpGaD
